Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L P Xu

Showing results (31-40 of 154) with videos related to

Pageof 16
Sort By:
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Impact of blood count recovery before haploidentical stem cell transplantation on outcomes in acute myeloid leukemia]C Zhao, Y Q Sun, L P Xu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 19, 2019
[Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy]Y Chen, X H Zhang, L P Xu, et al.
Leukemia|December 7, 2005
Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemiaX-J Huang, D-H Liu, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016
[Comparison of immune reconstitution at early stage after unmanipulated haploidentical stem cell transplantation between high- and standard- risk Philadelphia chromosome- negative acute lymphoblastic leukemia patients in CR1]Z L Bian, Y J Chang, L P Xu, et al.
British Journal of Cancer|August 1, 2014
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patientsX-Y Zhao, Y-J Chang, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia]X J Liu, X J Huang, L P Xu, et al.
Bone Marrow Transplantation|August 15, 2017
Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantationX-Y Pei, X-Y Zhao, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2018
[Impact of mycophenolate mofetil prophylaxis duration on acute graft-versus-host disease after haploidentical stem cell transplantation]Y Q Sun, X J Huang, L P Xu, et al.
Bone Marrow Transplantation|April 30, 2014
EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantationH-T Wang, Y-J Chang, L-P Xu, et al.
Zhonghua Nei Ke Za Zhi|January 11, 2023
[Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation]R Ma, Y He, L P Xu, et al.
Pageof 16

Showing results (31-40 of 154) with videos related to

Sort By:
Pageof 16
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|January 20, 2022
[Impact of blood count recovery before haploidentical stem cell transplantation on outcomes in acute myeloid leukemia]C Zhao, Y Q Sun, L P Xu, et al.
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 19, 2019
[Haploidentical allogenetic hematopoietic stem cell transplantation for X-linked adrenoleukodystrophy]Y Chen, X H Zhang, L P Xu, et al.
Leukemia|December 7, 2005
Prophylactic infusion of donor granulocyte colony stimulating factor mobilized peripheral blood progenitor cells after allogeneic hematological stem cell transplantation in patients with high-risk leukemiaX-J Huang, D-H Liu, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|September 3, 2016
[Comparison of immune reconstitution at early stage after unmanipulated haploidentical stem cell transplantation between high- and standard- risk Philadelphia chromosome- negative acute lymphoblastic leukemia patients in CR1]Z L Bian, Y J Chang, L P Xu, et al.
British Journal of Cancer|August 1, 2014
HLA and KIR genotyping correlates with relapse after T-cell-replete haploidentical transplantation in chronic myeloid leukaemia patientsX-Y Zhao, Y-J Chang, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|April 1, 2019
[Effects of pre-transplant course on prognosis of allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia]X J Liu, X J Huang, L P Xu, et al.
Bone Marrow Transplantation|August 15, 2017
Immune reconstitution in patients with acquired severe aplastic anemia after haploidentical stem cell transplantationX-Y Pei, X-Y Zhao, L-P Xu, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|May 21, 2018
[Impact of mycophenolate mofetil prophylaxis duration on acute graft-versus-host disease after haploidentical stem cell transplantation]Y Q Sun, X J Huang, L P Xu, et al.
Bone Marrow Transplantation|April 30, 2014
EBMT risk score can predict the outcome of leukaemia after unmanipulated haploidentical blood and marrow transplantationH-T Wang, Y-J Chang, L-P Xu, et al.
Zhonghua Nei Ke Za Zhi|January 11, 2023
[Clinical analysis of the efficacies of ganciclovir plus foscarnet and a single antiviral drug for the treatment of cytomegalovirus infection after haploidentical stem cell transplantation]R Ma, Y He, L P Xu, et al.
Pageof 16